Background: 56MESS has been shown to be cytotoxic but the mode of this action is unclear. In order to probe the mechanism of action for 56MESS, MDCK cells were utilised to investigate the effect on treated cells. Results: IC 50 values for 56MESS and cisplatin in the MDCK cell line, determined by a SRB assay, were 0.25 ± 0.03 and 18 ± 1.2 µM respectively. In a preliminary study, cells treated with 56MESS displayed no caspase-3/7 activity, suggesting that the mechanism of action is caspase independent. Protein expression studies revealed an increase the expression in the MTC02 protein associated with mitochondria in cells treated with 56MESS and cisplatin. Non-synchronised 56MESS-treated cells caused an arrest in the G2/M phase of the cell cy...
<p>Cellular exposure to cisplatin causes direct damage to mtDNA resulting in a reduction of mitochon...
<p>(<b>A</b>) Cells were stimulated with compound <b>1a</b> (5 µM) or vehicle (0.1% DMSO) for the ti...
<p>A: mitochondria of cells treated with 0.1 µM cisplatin (<i>cis</i>Pt). B: mitochondria of cells t...
© 2014 by the authors. Many clinically available anticancer compounds are designed to target DNA. Th...
Many clinically available anticancer compounds are designed to target DNA. This commonality of acti...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>(A) Mitochondrial membrane potentials of KYSE140 and EC0156 cells were determined using Mito Trac...
OBJECTIVES: Cisplatin (cisPt) is used as a chemotherapeutic agent for the treatment of a variety of ...
<div><p>The chemotherapeutic use of cisplatin is limited by its severe side effects. In this study, ...
<p>Cisplatin induced mitochondrial dysfunction through mitochondrial reactive oxygen species (mROS) ...
2014-04-28Transmembrane protein TMEM 56 was first identified as an IKK‐associated protein by mass sp...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
<p><b>A)</b> HCT116 clones were either untreated (NT) or treated with 15 µM cisplatin. At the 24 hr ...
<p>Survival of A549 cells after 72 h exposure to a dose range of either (<b>E</b>) cisplatin or (<b>...
<p>Representative flow cytometry curves of total intracellular ROS levels (H<sub>2</sub>DCFDA) in (<...
<p>Cellular exposure to cisplatin causes direct damage to mtDNA resulting in a reduction of mitochon...
<p>(<b>A</b>) Cells were stimulated with compound <b>1a</b> (5 µM) or vehicle (0.1% DMSO) for the ti...
<p>A: mitochondria of cells treated with 0.1 µM cisplatin (<i>cis</i>Pt). B: mitochondria of cells t...
© 2014 by the authors. Many clinically available anticancer compounds are designed to target DNA. Th...
Many clinically available anticancer compounds are designed to target DNA. This commonality of acti...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>(A) Mitochondrial membrane potentials of KYSE140 and EC0156 cells were determined using Mito Trac...
OBJECTIVES: Cisplatin (cisPt) is used as a chemotherapeutic agent for the treatment of a variety of ...
<div><p>The chemotherapeutic use of cisplatin is limited by its severe side effects. In this study, ...
<p>Cisplatin induced mitochondrial dysfunction through mitochondrial reactive oxygen species (mROS) ...
2014-04-28Transmembrane protein TMEM 56 was first identified as an IKK‐associated protein by mass sp...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
<p><b>A)</b> HCT116 clones were either untreated (NT) or treated with 15 µM cisplatin. At the 24 hr ...
<p>Survival of A549 cells after 72 h exposure to a dose range of either (<b>E</b>) cisplatin or (<b>...
<p>Representative flow cytometry curves of total intracellular ROS levels (H<sub>2</sub>DCFDA) in (<...
<p>Cellular exposure to cisplatin causes direct damage to mtDNA resulting in a reduction of mitochon...
<p>(<b>A</b>) Cells were stimulated with compound <b>1a</b> (5 µM) or vehicle (0.1% DMSO) for the ti...
<p>A: mitochondria of cells treated with 0.1 µM cisplatin (<i>cis</i>Pt). B: mitochondria of cells t...